A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice

PLoS Neglected Tropical Diseases

Volumn 4, Issue 4, 2010, Pages

  Tan, Grace K ^a   Ng, Jowin K W ^a   Trasti, Scott L ^a   Schul, Wouter ^b   Yip, George ^a   Alonso, Sylvie ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NOVARTIS INSTITUTE FOR TROPICAL DISEASES   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; CYTOKINE; INTERFERON RECEPTOR;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BLOOD VESSEL PERMEABILITY; CLEARANCE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DISEASE SEVERITY; MOUSE; MOUSE STRAIN; MOUSE STRAIN AG129; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; SURVIVAL RATE; VIREMIA; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; ANIMAL; ANIMAL ANATOMY; BLEEDING; DEATH; DISEASE MODEL; HUMAN; MOUSE MUTANT; PATHOGENICITY; PATHOLOGY; SECRETION; VIROLOGY;

ANIMAL STRUCTURES; ANIMALS; CYTOKINES; DEATH; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; DISEASE MODELS, ANIMAL; HEMORRHAGE; HUMANS; MICE; MICE, KNOCKOUT; RECEPTORS, INTERFERON;

EID: 77952380265     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000672     Document Type: Article

References (53)

1. st century. Trends Microbiol 10: 100-103.
2. Tolle MA (2009) Mosquito-borne diseases. Curr Probl Pediatr Adolesc Health Care 39: 97-140.
3. Halstead SB (2007) Dengue. Lancet 370: 1644-1652.
4. Guidelines for the clinical evaluation of dengue vaccines in endemic areas: Summary of a World Health Organization Technical Consultation. (2008) Vaccine 26: 4113-4119.
5. Martina BEE, Koraka P, Osterhaus ADME (2009) Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22: 564-581.
6. Lin CF, Wan SW, Cheng HJ, Lei HY, Lin YS (2006) Autoimmune pathogenesis in dengue virus infection. Viral Immunol 19: 127-132.
7. Cheng HJ, Lin CF, Lei HY, Liu HS, Yeh TM, et al. (2009) Proteomic analysis of endothelial cell autoantigens recognized by anti-dengue virus nonstructural protein 1 antibodies. Exp Biol Med (Maywood) 234: 63-73.
8. Kurosu T, Chaichana P, Yamate M, Anantapreecha S, Ikuta K (2007) Secreted complement regulatory protein clusterin interacts with dengue virus non structural protein 1. Biochem Biophys Res Commun 362: 1051-1056.
9. Chaturvedi UC, Nagar R, Shrivastava R (2006) Dengue and dengue hemorrhagic fever: implications of host genetics. FEMS Immunol Med Microbiol 47: 155-166.
10. Lan NT, Kikuchi M, Huong VT, Ha do Q, Thuy TT, et al. (2008) Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, Dengue Hemorrhagic Fever and Dengue Shock Syndrome. PLoS Negl Trop Dis 2: e304.
11. Fernández-Mestre MT, Gendzekhadze K, Rivas-Vetencourt P, Layrisse Z (2004) TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens 64: 469-472.
12. Pandey BD, Morita K, Hasebe F, Parquet MC, Igarashi A (2000) Molecular evolution, distribution and genetic relationship among the dengue 2 viruses isolated from different clinical severity. Southeast Asian J Trop Med Public Health 31: 266-272.
13. Leitmeyer KC, Vaughn DW, Watts DM, Salas R, Villalobos I, et al. (1999) Dengue virus structural differences that correlate with pathogenesis. J Virol 73: 4738-4747.
14. Tan GK, Alonso S (2009) Pathogenesis and prevention of dengue virus infection: state-of-the-art. Curr Opin Infect Dis 22: 302-308.
15. Yauch LE, Sheresta S (2008) Mouse models of dengue virus infection and disease. Antiviral Res 80: 87-93.
16. Halstead SB, Shotwell H, Casals J (1973) Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection. J Infect Dis 128: 7-14.
17. Scherer WF, Russell PK, Rosen L, Casals J, Dickerman RW (1978) Experimental infection of chimpanzees with dengue viruses. Am J Trop Med Hyg 27: 590-599.
18. Onlamoon N, Noisakran S, Hsiao HM, Duncan A, Villinger F, et al. (2009) Dengue virus induced hemorrhage in a nonhuman primate model. Blood ahead of print.
19. Sun W, Nisalak A, Gettayacamin M, Eckels KH, Putnak JR, et al. (2006) Protection of rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination. J Infect Dis 193: 1658-1665.
20. Blaney Jr. JE, Matro JM, Murphy BR, Whitehead SS (2005) Recombinant, live attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys. J Virol 79: 5516-5528.
21. Sabin AB, Schlesinger RW (1945) Production of immunity to dengue with virus modified by propagation in mice. Science 101: 640-642.
22. Cole GA, Wisseman Jr. CL (1969) Pathogenesis of type 1 dengue virus infection in suckling, weanling and adult mice. 1. The relation of virus replication to interferon and antibody formation. Am J Epidemiol 89: 669-680.
23. Wu SJ, Hayes CG, Dubois DR, Windheuser MG, Kang YH, et al. (1995) Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection. Am J Trop Med Hyg 52: 468-476.
24. Lin YL, Liao CL, Chen LK, Yeh CT, Liu CI, et al. (1998) Study of dengue virus infection in SCID mice engrafted with human K562 cells. J Virol 72: 9729-9737.
25. An J, Kimura-Kuroda J, Hirabayashi Y, Yasui K (1999) Development of a novel mouse model for dengue virus infection. Virology 263: 70-77.
26. Blaney Jr. JE, Johnson DH, Manipon GG, Firestone CY, Hanson CT, et al. (2002) Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells. Virology 300: 125-139.
27. Bente DA, Melkus MW, Garcia JV, Rico-Hesse R (2005) Dengue fever in humanized NOD/SCID mice. J Virol 79: 13797-13799.
28. Hotta H, Murakami I, Miyasaki K, Takeda Y, Shirane H, et al. (1981) Inoculation of dengue virus into nude mice. J Gen Virol 52: 71-76.
29. Shresta S, Kyle JL, Snider HM, Basavapatna M, Beatty PR, et al. (2004) Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity is less critical. J Virol 78: 2701-2710.
30. Shresta S, Sharar KL, Prigozhin DM, Beatty PR, Harris E (2006) Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol 80: 10208-10217.
31. Johnson AJ, Roehrig JT (1999) New mouse model for dengue virus vaccine testing. J Virol 73: 783-786.
32. Schul W, Liu W, Xu HY, Flamand M, Vasudevan SG (2007) A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. J Infect Dis 195: 665-674.
33. Williams KL, Zompi S, Beatty PR, Harris E (2009) A mouse model for studying dengue virus pathogenesis and immune response. Immunology and pathogenesis of viral hemorrhagic fevers: Ann NY Acad Sci 1171: E12-E23.
34. Nimmannitya S, Halstead SB, Cohen S, Margiotta MR (1969) Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg 18: 954-971.
35. Nisalak A, Halstead SB, Singharaj P, Udomsakdi S, Nye SW, et al. (1970) Observations related to pathogenesis of dengue hemorrhagic fever. III. Virologic studies of fatal disease. Yale J Biol Med 42: 293-310.
36. Sim AC, Lin W, Tan GK, Sim MS, Chow VT, et al. (2008) Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen. Vaccine 26: 1145-1154.
37. Schumacher J, Binkowski K, Dendorfer A, Klotz KF (2003) Organ-specific extravasation of albumin-bound Evans blue during nonresuscitated hemorrhagic shock in rats. Shock 20: 565-568.
38. Whitehead SS, Blaney Jr. JE, Durbin AP, Murphy BR (2007) Prospects for a dengue virus vaccine. Nat Rev Microbiol 5: 518-528.
39. Basu A, Chaturvedi UC (2008) Vascular endothelium: the battlefield of dengue viruses. FEMS Immunol Med Microbiol 53: 287-299.
40. Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS (2000) Cytokine cascade in Dengue haemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol 28: 183-188.
41. Binh PT, Matheua S, Huong VTQ, Deparis X, Marechal V (2009) Early clinical and biological features of severe clinical manifestations of dengue in Vietnamese adults. J Clin Virol 45: 276-280.
42. Tanner L, Schreiber M, Low JG, Ong A, Tolfvenstam T, et al. (2009) Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illness. PLoS Negl Trop Dis 2: e196.
43. Chen HC, Hofman FM, Kung JT, Lin YD, Wu-Hsieh BA (2007) Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol 81: 5518-5526.
44. Wu-Hsieh BA, Yen YT, Chen HC (2009) Dengue hemorrhage in a mouse model. Immunology and pathogenesis of viral hemorrhagic fevers: Ann NY Acad Sci 1171: E42-E47.
45. Mota J, Rico-Hesse R (2009) Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J Virol 83: 8638-8645.
46. Patey O, Ollivaud L, Breuil J, Lafaix C (1993) Unusual neurologic manifestations occurring during dengue fever infection. Am J Trop Med Hyg 48: 793-802.
47. Lum LC, Lam SK, Choy YS, George R, Harun F (1996) Dengue encephalitis: a true entity? Am J Trop Med Hyg 54: 256-259.
48. Trung DT, Wills B (2010) Systemic vascular leakage associated with dengue infections-the clinical perspective. Curr Top Microbiol Immunol 338: 57-66.
49. Beynon HL, Haskard DO, Davies K, Haroutunian R, Walport MJ (1993) Combination of low concentrations of cytokines and acute agonists synergize in increasing the permeability of endothelial monolayers. Clin Exp Immunol 91: 314-319.
50. Chen MC, Lin CF, Lei HY, Lin SC, Liu HS, et al. (2009) Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency. J Immunol 183: 1797-1803.
51. Cheng HJ, Lei HY, Lin CF, Luo YH, Wan SW, et al. (2009) Anti-dengue virus non-structural protein 1 antibodies recognize protein disulfide isomerise on platelets and inhibit platelet aggregation. Mol Immunol 47: 398-406.
52. Honda S, Saito M, Dimaano EM, Morales PA, Alonzo MTG, et al. (2009) Increased phagocytosis of platelets from patients with secondary dengue virus infection by human macrophages. Am J Trop Med Hyg 80: 841-845.
53. Noisakran S, Chokephaibulkit K, Songprakhon P, Onlamoon N, Hsiao HM, et al. (2009) A re-evaluation of the mechanisms leading to dengue hemorrhagic fever. Immunology and pathogenesis of viral hemorrhagic fevers: Ann NY Acad Sci 1171: E24-E35.